Table 2 Patient characteristics.
Participant number | Age | Gender | BMI | Years since diagnosis | Therapy | Total units of insulin injection per day | Total units of insulin injection per day/BW (kg) | HbA1c (%) of baseline | Fasting serum CPR (ng/ml) |
|---|---|---|---|---|---|---|---|---|---|
1 | 46.4 | Female | 18.1 | 1.3 | MDI | 20.0 | 0.43 | 7.4 | 0.277 |
2 | 74.2 | Female | 14.9 | 13.3 | MDI | 27.0 | 0.86 | 9.5 | < 0.01 |
3 | 61.7 | Male | 29.7 | 19.3 | CSII | 48.2 | 0.66 | 9.3 | < 0.01 |
4 | 70.7 | Female | 22.0 | 25.8 | CSII | 51.6 | 1.04 | 7.4 | < 0.01 |
5 | 34.2 | Female | 25.0 | 1.2 | CSII | 48.0 | 0.82 | 6.5 | < 0.01 |
6 | 70.5 | Female | 20.6 | 30.8 | MDI | 32.0 | 0.69 | 6.4 | < 0.01 |
7 | 70.9 | Female | 20.3 | 23.8 | MDI | 8.0 | 0.18 | 6.3 | 1.21 |
8 | 55.2 | Female | 20.3 | 0.7 | MDI | 23.0 | 0.44 | 6.7 | 1.13 |
9 | 38.4 | Female | 23.6 | 3.8 | CSII | 25.5 | 0.39 | 8.6 | < 0.01 |
10 | 30.5 | Male | 27.9 | 14.8 | CSII | 50.2 | 0.63 | 11.5 | < 0.01 |
11 | 32.3 | Female | 21.0 | 0.6 | CSII | 32.5 | 0.76 | 7.5 | < 0.01 |
12 | 62.3 | Male | 19.6 | 1.4 | MDI | 33.0 | 0.53 | 7.2 | 0.311 |
13 | 39.0 | Female | 18.9 | 0.9 | CSII | 34.0 | 0.74 | 6.2 | 0.409 |
14 | 42.6 | Male | 27.5 | 9.0 | MDI | 53.0 | 0.65 | 7.2 | < 0.01 |
15 | 43.2 | Male | 23.0 | 3.6 | CSII | 30.4 | 0.45 | 7.7 | 0.318 |
16 | 63.1 | Female | 16.8 | 4.0 | MDI | 17.0 | 0.42 | 7.3 | 0.064 |
17 | 53.1 | Male | 23.2 | 1.9 | MDI | 15.0 | 0.19 | 6.7 | 0.931 |
18 | 75.8 | Female | 21.1 | 5.0 | MDI | 18.0 | 0.37 | 8.2 | 0.285 |
19 | 45.3 | Female | 19.1 | 6.3 | CSII | 26.0 | 0.55 | 7.2 | 0.030 |
Total or mean ± SD | 53.1 ± 15.2 | Female: 13, Male: 6 | 21.7 ± 3.8 | 8.8 ± 9.6 | MDI: 10, CSII: 9 | 31.2 ± 13.5 | 0.57 ± 0.22 | 7.6 ± 1.3 | 0.261 ± 0.397a |